.png){kind=logo}
Healthcare companies continue to show strong financial performance across pharmaceutical and hospital segments.
Low debt and healthy profitability remain common strengths among several market leaders.
Each stock offers a different mix of valuation, growth potential, and long-term business strength.
The healthcare sector stands as one of the strongest parts of the Indian stock market. Demand for medicines, hospital services, diagnostic care, and medical research supports steady business growth across many companies.
Strong financial performance, healthy profit levels, and expansion into new markets help several healthcare businesses maintain investor confidence. Large companies with established brands, solid management, and wide product portfolios continue to deliver stable results even during changing market conditions.
The following healthcare companies rank among the leading names in the sector. Their market value, valuation, profitability, returns, and financial strength present a detailed picture of their current position.
Sun Pharmaceuticals Industries Limited is the most important company in the list with market capitalization of Rs. 4,68,110.25 crore. It is a pharma company and one of the biggest drug manufacturers in India. The stock ended the day with a price of Rs. 1,951.00 and PE ratio of 40.78.
The stock has grown by 0.57% in one day; gained 2.43% in one month; increased by 15.10% in six months; and gone up by 22.30% over the year. Its price-to-book ratio is 5.58 and return on equity is 14.68%, while ROCE is 18.02%. It is offering dividend yield of around 0.82% and shows a debt-to-equity ratio of 0.06, thus indicating lower debt.
Divi's Laboratories Ltd is part of the laboratory and life sciences services business. The company has a market capitalization of Rs. 2,21,639.72 crore and is currently trading at a price of Rs. 8,349.00 per share, with a PE ratio of 86.31.
The stock faced a 0.46% decline in a single day but has performed well overall, returning 22.96% in one month, 38.58% in six months, and 36.12% in one year. The company's price-to-book ratio stands at 13.22, return on equity at 16.19%, and ROCE at 18.98%. Additionally, the company has a dividend yield of 0.36%. The company has a debt-to-equity ratio of 0.00.
Torrent Pharmaceuticals Ltd holds a market valuation of Rs. 1,88,510.31 crore. The company is quoted at Rs. 4,956.00, accompanied by a PE ratio of 87.14. Investors appear to appreciate the company, especially for its diversity in each segment of therapy.
There was a negative variation of 0.88% in the stock price. Although there was an upside of 3.38% in the stock within a month, 25.82% in six months, and 40.63% over a year. The price-to-book ratio is 10.72, while return on equity stands at 17.19% and ROCE is 9.24%. The dividend yield is 0.68%. A debt equity ratio of 0.85 indicates that the company borrows moderately, whereas volatility remains at 1.52 as compared to Nifty.
Apollo Hospitals Enterprise Limited is one of India's leading hospital operators. The company's market cap is Rs. 129,039.54 crore, with stock trading prices at Rs. 8,974.50. Apollo Hospitals has a PE ratio of 66.46, indicating strong confidence from investors.
The stock recorded a rise of 0.72% in a day. The returns over one month, six months, and one year are 0.76%, 25.47%, and 24.83%, respectively. Its price-to-book ratio is 12.93, ROE is 18.42%, and ROCE is 19.81%. The company has a dividend yield of 0.22%. The debt-equity ratio indicates its financial leverage at a moderate level of 0.85.
Also Read - AI in Drug Discovery: A Game-Changer for the Pharmaceutical Industry
Cipla Ltd remains one of India's most established pharmaceutical companies. It holds a market capitalization of Rs. 1,19,319.91 crore. The stock closed at Rs. 1,477.00, while the PE ratio stands at 30.76, which ranks among the lower valuations in this group.
The share price rose 1.25% in one day. The stock returned 0.96% in one month and 11.05% in six months, while the one-year return stands at -0.65%. The price-to-book ratio comes at 3.46. Return on equity reaches 11.79%, while ROCE stands at 14.94%. The dividend yield remains 0.88%. A debt-to-equity ratio of 0.02 reflects excellent financial discipline. Volatility against the Nifty stands at 1.51.
With a market capitalization of Rs. 1,10,523.42 crore, Zydus Lifesciences Ltd is part of the pharmaceutical sector. The stock was valued at Rs. 1,108.00, with a PE ratio of 21.93, being one among the companies with the second-lowest valuation.
The stock has decreased by 1.17% in a day and by 3.23% in a month. Despite the recent decline, it has given a return of 24.75% in six months and 18.79% in one year. The company has a price-to-book ratio of 3.74, return on equity at 18.02%, and a return on capital employed (ROCE) of 20.19%.
The company's dividend yield is at 0.09%, while the debt-equity ratio of 0.42 indicates a healthy extent of leverage, with its compliance with borrowings and the stock volatility ratio with respect to Nifty at 1.55.
Lupin Limited holds a market capitalization of Rs. 1,09,050.52 crore and trades at Rs. 2,385.00. The PE ratio stands at 20.45, the lowest among the companies listed here.
The stock slipped 0.13% in one day and 4.52% over one month. Even after recent pressure, it produced 9.72% returns in six months and 28.79% in one year. The price-to-book ratio comes at 4.84. Return on equity reaches 26.79%, while ROCE stands at 28.66%, the highest figures in this group. The dividend yield remains 0.75%. A debt-to-equity ratio of 0.29 reflects comfortable leverage. Volatility against the Nifty stays at 1.37.
Max Healthcare Institute Limited operates in the hospitals and diagnostic centers segment. The company has a market capitalization of Rs. 1,04,373.84 crore. The stock closed at Rs. 1,072.40, with a PE ratio of 72.36.
The share price declined 0.70% in one day, 7.37% in one month, and 15.63% over one year. Even so, it recorded 3.13% growth during the last six months. The company reports a price-to-book ratio of 9.71, return on equity of 14.33%, and ROCE of 12.74%. The dividend yield stands at 0.19%. The debt-to-equity ratio remains 0.32, while volatility against the Nifty comes at 1.82.
Mankind Pharma Ltd is strongly positioned in the prescription medicine and consumer healthcare product market and is valued at Rs. 99,957.42 crore. The closing price of the shares is Rs. 2,420.30 with a PE ratio of 52.25.
The stock has decreased in value by 0.63% within just one day and by 4.66% across one month. Yet, it has provided returns of 17.48% over six months. As for the one-year return, it is at -5.32%. The price-to-book ratio is 6.04, while the return on equity is 12.29% with ROCE at 14.01%. The dividend yield is 0.04%. The debt-to-equity ratio is 0.38, and volatility against Nifty is 1.81.
Laurus Labs Ltd completes this list with a market capitalization of Rs. 98,877.14 crore. The company trades at Rs. 1,830.00, while the PE ratio stands at 111.25, the highest valuation among these healthcare stocks.
The stock declined 0.27% in one day. It produced impressive returns of 18.37% in one month, 92.52% in six months, and 118.85% over one year, which marks the strongest price performance in this group. The company reports a price-to-book ratio of 18.20, return on equity of 17.72%, and ROCE of 19.67%. The dividend yield stands at 0.11%. A debt-to-equity ratio of 0.46 reflects moderate borrowing, while volatility against the Nifty comes at 2.06.
Also Read - AI Doctors Assisting Real-Time Diagnosis
The healthcare industry of India is composed of pharmaceutical manufacturers, research organizations, hospitals, and diagnostic service firms, which are economically strong companies. The company with the highest market capitalization is Sun Pharmaceutical Industries; Divi's Laboratories has a zero-debt balance sheet,
Lupin has the highest return on equity and return on capital employed value, and Laurus Labs is the highest stock return performer for one year. Apollo Hospitals and Max Healthcare represent the hospital segment with operationally strong companies, while the pharmaceutical companies Cipla and Zydus Lifesciences have well-established operations and reasonable valuation.
Each of these companies has a unique mix of growth, profitability, valuation, and financial performance, allowing for their inclusion in the list of significant healthcare businesses in India.
Sun Pharmaceutical Industries Ltd leads the sector with the highest market capitalization of Rs. 4,68,110.25 crore, making it the largest drug manufacturer on the list.
Lupin Limited trades at a Price-to-Earnings (P/E) ratio of 20.45, making it the lowest-valued stock by P/E among the top healthcare companies listed.
Laurus Labs Ltd delivered the strongest 1-year price performance in the group, with an impressive 118.85% return.
Divi's Laboratories Ltd maintains a completely debt-free balance sheet with a debt-to-equity ratio of 0.00.
Apollo Hospitals Enterprise Limited (market cap: Rs. 129,039.54 crore) and Max Healthcare Institute Limited (market cap: Rs. 104,373.84 crore) represent the core hospital and diagnostic healthcare space.
Lupin Limited reports the highest profitability metrics in the group, with a Return on Equity (ROE) of 26.79% and a Return on Capital Employed (ROCE) of 28.66%.
Cipla Ltd provides the highest dividend yield among these companies at 0.88%, closely followed by Sun Pharmaceutical Industries Ltd at 0.82%.
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be risky, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more about the financial risks involved here.
